Alto Neuroscience Inc [ANRO] stock is trading at $13.62, up 11.18%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ANRO shares have gain 25.53% over the last week, with a monthly amount glided 239.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alto Neuroscience Inc [NYSE: ANRO] stock has seen the most recent analyst activity on September 29, 2025, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $15. Previously, Wedbush downgraded its rating to Neutral on October 23, 2024, and dropped its price target to $4. On October 23, 2024, downgrade downgraded it’s rating to Neutral. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $29 on September 03, 2024. William Blair initiated its recommendation with a Outperform. In a note dated February 27, 2024, Stifel initiated an Buy rating and provided a target price of $32 on this stock.
Alto Neuroscience Inc [ANRO] stock has fluctuated between $1.60 and $12.71 over the past year. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Alto Neuroscience Inc [NYSE: ANRO] shares were valued at $13.62 at the most recent close of the market. An investor can expect a potential return of 17.47% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Gross Profit Margin for this corporation currently stands at -0.7% with Operating Profit Margin at -178.28%, Pretax Profit Margin comes in at -164.62%, and Net Profit Margin reading is -164.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.45 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.33 points at the first support level, and at 11.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.32, and for the 2nd resistance point, it is at 15.01.
Ratios To Look Out For
For context, Alto Neuroscience Inc’s Current Ratio is 18.43. In addition, the Quick Ratio stands at 18.43 and the Cash Ratio stands at 18.16.
